Advocacy

COVID-19 resources and guidance from funding agencies

National Institutes of Health

The National Institutes of Health has released a number of guidances about grant proposals, animal care, study sections and more. It also has COVID-19-related funding opportunities and a frequently asked questions page. See the main landing page, and the FAQ on COVID-19 flexibilities for applicants and recipients.

Proposal submission and award management

Peer review

Based on NIH Guidance on Travel and Meetings, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.

Virtual meetings

Webinar on animal care

Earlier this week, the NIH Office of Laboratory Animal Welfare put on a webinar titled "Pandemic Contingency Planning and Its Impact on Animal Care."

Soliciting research and medical products for Coronavirus Disease 2019 (COVID-19)

HHS solicits proposals for the development of medical products for the novel coronavirus. The Biomedical Advanced Research and Development authority (BARDA) issued BAA-18-100-SOL-00003-Amendment 13, to solicit proposals for advanced development of COVID-19 diagnostics, vaccines or medicines such as therapeutics or antivirals.

The National Institute of General Medical Sciences (NIGMS) published a notice of special interest (NOT-GM-20-025) to address the urgent need for research on the SARS-CoV-2 virus. They will accept competitive revisions (supplements) in three specific scientific areas:

  1. Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive models for the spread of SARS-CoV-2 and other related infectious agents (all relevant grants)
  2. Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only)
  3. Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR grants only)

National Science Foundation

The National Science Foundation also released guidances about grants and deadlines and posted a frequently asked questions page. See the landing page and a letter to the community regarding COVID-19.

NSF notice for peer reviewers

The NSF issued a statement on March 9 that will be of interest to anyone participating on review panels. Here's a nugget: "Reviewers participating in panel sessions for a minimum of four hours are eligible to receive compensation at the NSF virtual panelist compensation rate." Read it here.

See also: Administrative relief for recipients and applicants of federal financial assistance directly impacted by the novel coronavirus (COVID-19) due to loss of operations

Department of Energy Office of Science

The DOE’s Office of Science doesn't have a page dedicated to COVID-19 for grantees, but it did release this letter about the scientific infrastructure available to researchers. It says, in part, "Through its user facilities, computational power, and enabling infrastructure, DOE has unique capabilities that the scientific community may leverage for the COVID-19 response and recovery. Read the letter.

Other resources

Free sequencing panel for coronavirus researchers

Arbor Biosciences is offering the research community a free myBaits Expert hybridization-based panel for the 2019 coronavirus. A company press release said: "The myBaits Expert 2019-nCoV panel is based on all full and partial genome sequences available in the NCBI database." See the full release and contact info.